NR4A1 and breast cancer: In ER + BC tumors, across HSD3B1 genotypes in both pre- and postmenopausal tumors, there was minimal variation in the transcriptome, including in the expression of canonical hormone receptor genes (ESR1, ESR2, PGR) (Figure 4, and Supplementary Table S4).